Butyrate inhibits glucose transport and glycolysis in CRC cells by reducing the abundance of membrane GLUT1 and cytoplasm G6PD and improves the chemotherapy effect of 5 - FU. Here, SLC2A1 is linked to colorectal carcinoma.